title: Lifestyle modifies the relationship between body composition and adrenergic receptor genetic polymorphisms, ADRB2, ADRB3 and ADRA2B: a secondary analysis of a randomized controlled trial of physical activity among postmenopausal women.
abstract: Genetic variations in the adrenergic receptor (ADR) have been associated with body composition in cross-sectional studies. Recent findings suggest that ADR variants may also modify body composition response to lifestyle. We assessed the role of ADR variants in body composition response to 12 months of resistance training versus control in previously sedentary postmenopausal women. Randomized trial completers were genotyped for A2B (Glu9/12) by fragment length analysis, and B2 (Gln27Glu) and B3 (Trp64Arg) by TaqMan (n = 148, 54% hormone therapy users). Associations between genotypes and body composition, by dual energy X-ray absorptiometry, were analyzed using univariate models. There was no main effect of individual genes on change in body composition, however, gene x exercise interactions were observed for A2B (Glu9/12) and B2 (Gln27Glu) on change in lean soft tissue (LST, p = 0.02); exercisers on the A2B (Glu9-) background gained LST compared to a loss among controls over 12 months (p < 0.05), with no significant intervention effect on the A2B (Glu9+) background. Similarly, there was a significant LST gain with exercise on the B2 (Glu27+) background compared to loss among controls and no intervention effect on the B2 (Glu27-) background. A non-significant association between total body fat (TBF) and B3 (Trp64Arg) persisted among sedentary controls only when intervention groups were separated (%TBF gain with B3 (Arg64+) carriage, p = 0.03); exercisers lost TBF regardless of genotype. In summary, effect modification by lifestyle was demonstrated on ADRA2B, B2, and B3 genetic backgrounds. Individuals with certain ADR genotypes may be more vulnerable to adverse changes in body composition with sedentary behavior, thus these candidate genes warrant further study.
authors.affiliation: Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA. jbea@azcc.arizona.edu
authors.forename: Jennifer W
authors.initials: JW
authors.lastname: Bea
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Lohman
authors.forename: Ellen C
authors.initials: EC
authors.lastname: Cussler
authors.forename: Scott B
authors.initials: SB
authors.lastname: Going
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Thompson
mesh_terms: D000483:Alleles; D001823:Body Composition / Q000235:genetics*; D015444:Exercise / Q000502:physiology; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics*; D017698:Postmenopause / Q000502:physiology; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics*; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics*; D022702:Receptors, Adrenergic, beta-3 / Q000235:genetics*
chemical_list: C547771:ADRA2B protein, human; D018341:Receptors, Adrenergic, alpha-2; D018343:Receptors, Adrenergic, beta-2; D022702:Receptors, Adrenergic, beta-3
references.citation: N Engl J Med. 1995 Aug 10;333(6):382-3
references.pmid: 7609759
references.citation: Eur J Appl Physiol Occup Physiol. 1981;46(4):339-45
references.pmid: 6266825
references.citation: Obes Res. 2001 Jun;9(6):337-41
references.pmid: 11399779
references.citation: Annu Rev Pharmacol Toxicol. 2003;43:381-411
references.pmid: 12540746
references.citation: Int J Obes Relat Metab Disord. 1998 Jun;22(6):559-66
references.pmid: 9665677
references.citation: Diabetes. 1999 Jan;48(1):117-20
references.pmid: 9892231
references.citation: Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S5-S10
references.pmid: 19037213
references.citation: Eur J Appl Physiol Occup Physiol. 1990;60(6):418-24
references.pmid: 2167842
references.citation: Med Sci Sports Exerc. 2003 Apr;35(4):555-62
references.pmid: 12673136
references.citation: Int J Obes Relat Metab Disord. 2002 Nov;26(11):1434-41
references.pmid: 12439644
references.citation: Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S11-22
references.pmid: 19190620
references.citation: Int J Obes Relat Metab Disord. 2001 Nov;25(11):1609-14
references.pmid: 11753579
references.citation: Osteoporos Int. 2003 Aug;14(8):637-43
references.pmid: 12844212
references.citation: Lancet. 1999 Mar 13;353(9156):896
references.pmid: 10093985
references.citation: Int J Obes (Lond). 2009 Jan;33(1):29-36
references.pmid: 19048013
references.citation: J Physiol. 2002 Sep 1;543(Pt 2):399-411
references.pmid: 12205177
references.citation: Pharmacol Rev. 2004 Mar;56(1):31-52
references.pmid: 15001662
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):34-41
references.pmid: 7908124
references.citation: Med Sci Sports Exerc. 2005 Jun;37(6):881-903
references.pmid: 15947712
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):687-96
references.pmid: 11401920
references.citation: Am J Clin Nutr. 2009 Apr;89(4):1011-8
references.pmid: 19225119
references.citation: J Clin Endocrinol Metab. 1999 Jul;84(7):2429-33
references.pmid: 10404816
references.citation: Mol Endocrinol. 2004 Sep;18(9):2123-31
references.pmid: 15243132
references.citation: J Clin Invest. 1993 Jan;91(1):344-9
references.pmid: 8380813
references.citation: Chin Med J (Engl). 2005 Nov 5;118(21):1797-802
references.pmid: 16336817
references.citation: Obes Res. 2003 May;11(5):612-8
references.pmid: 12740450
references.citation: Obes Res. 2004 May;12(5):807-15
references.pmid: 15166301
references.citation: J Gerontol A Biol Sci Med Sci. 2007 Jun;62(6):658-63
references.pmid: 17595424
references.citation: J Biol Chem. 2001 Feb 16;276(7):4917-22
references.pmid: 11056163
references.citation: Eur J Biochem. 1997 Aug 1;247(3):1174-9
references.pmid: 9288945
references.citation: Diabetes Obes Metab. 2002 Nov;4(6):428-30
references.pmid: 12406043
references.citation: Diabetes. 1999 Jan;48(1):203-5
references.pmid: 9892244
references.citation: J Hypertens. 2005 Dec;23(12):2201-7
references.pmid: 16269962
references.citation: Obesity (Silver Spring). 2006 Apr;14(4):529-644
references.pmid: 16741264
references.citation: J Appl Physiol (1985). 2004 Feb;96(2):526-30
references.pmid: 14715679
references.citation: Diabetes. 2001 Jan;50(1):91-5
references.pmid: 11147800
references.citation: Osteoporos Int. 2005 Dec;16(12):2129-41
references.pmid: 16283062
references.citation: Circ Res. 2000 Apr 28;86(8):834-40
references.pmid: 10785504
references.citation: Endocr Rev. 1993 Feb;14(1):72-93
references.pmid: 8491156
references.citation: J Intern Med. 1999 Jun;245(6):667-72
references.pmid: 10395196
references.citation: Am J Clin Nutr. 1995 Feb;61(2):274-8
references.pmid: 7840063
references.citation: Am J Physiol. 1998 Dec;275(6):E909-16
references.pmid: 9843731
references.citation: Nat Rev Genet. 2009 Apr;10(4):241-51
references.pmid: 19293820
references.citation: Trends Pharmacol Sci. 2001 Sep;22(9):471-7
references.pmid: 11543875
references.citation: Obesity (Silver Spring). 2008 Dec;16 Suppl 3:S95-6
references.pmid: 19037222
references.citation: Pharmacol Ther. 2008 Jan;117(1):1-29
references.pmid: 17916379
references.citation: Med Sci Sports Exerc. 2004 Sep;36(9):1451-69
references.pmid: 15354024
references.citation: J Nutr Biochem. 2003 May;14(5):275-9
references.pmid: 12832031